A novel 13C labeling scheme excluding the 2-carbon of long chain fatty acids resolves signal overlap in 13C-NMR, enabling accurate measurement of cardiac fatty acid oxidation.
Answers are grounded in this paper and cite their sources.
May refine LCFA oxidation assessment in animal models; extends 13C-NMR methods but leaves open human translation.
Purpose Long chain fatty acid (LCFA) oxidation measurements in the intact heart from 13C‐NMR rely on detection of 13C‐enriched glutamate. However, progressive increases in overlapping resonance signal from LCFA can confound detection of the glutamate 4‐carbon (GLU‐C4) signal. We evaluated alternative 13C labeling for exogenous LCFA and developed a simple scheme to distinguish kinetics of LCFA uptake and storage from oxidation. Methods Sequential 13C‐NMR spectra were acquired from isolated rat hearts perfused with 13C LCFA and glucose. Spectra were evaluated from hearts supplied: U 13C LCFA, [2,4,6,8,10,12,14,16‐13C8] palmitate, [2,4,6,8,10,12,14,16,18‐13C9] oleate, [4,6,8,10,12,14,16‐13C7] palmitate, or [4,6,8,10,12,14,16,18‐13C8] oleate. Results 13C signal reflected the progressive enrichment at 34.6 ppm from GLU‐C4, confounded by additional signal with distinct kinetics attributed to 13C‐enriched LCFA 2‐carbon (34.0 ppm). Excluding 13C at the 2‐carbon of both palmitate and oleate eliminated signal overlap and enabled detection of the exponential enrichment of GLU‐C4 for assessing LCFA oxidation. Conclusion Eliminating enrichment at the 2‐carbon of 13C LCFA resolved confounding kinetics between GLU‐C4 and LCFA 2‐carbon signals. With this enrichment scheme, oxidation of LCFA, the primary fuel for cardiac ATP synthesis, can now be more consistently examined in whole organs with dynamic mode, proton‐decoupled 13C‐NMR. Magn Reson Med 74:330–335, 2015.
No takes yet. Share an insight, caveat, or question.
O’Donnell et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: